The store will not work correctly when cookies are disabled.
2-benzyl-8-methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole
ID: ALA4856643
Cas Number: 70539-84-3
PubChem CID: 6619043
Max Phase: Preclinical
Molecular Formula: C19H20N2
Molecular Weight: 276.38
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1ccc2[nH]c3c(c2c1)CN(Cc1ccccc1)CC3
Standard InChI: InChI=1S/C19H20N2/c1-14-7-8-18-16(11-14)17-13-21(10-9-19(17)20-18)12-15-5-3-2-4-6-15/h2-8,11,20H,9-10,12-13H2,1H3
Standard InChI Key: HLKQPYUVQYSQSX-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 24 0 0 0 0 0 0 0 0999 V2000
13.5646 -18.0472 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.8988 -17.5668 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1534 -16.7906 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6089 -16.1840 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8098 -16.3525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5581 -17.1330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1042 -17.7362 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9689 -16.7901 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2186 -17.5645 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0097 -17.7345 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5567 -17.1330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3070 -16.3586 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.5102 -16.1857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8557 -15.7530 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6545 -15.9255 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9004 -16.7032 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6983 -16.8758 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2480 -16.2699 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9942 -15.4887 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1968 -15.3198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2629 -15.7454 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 9 1 0
8 3 1 0
2 1 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 2 1 0
8 9 2 0
8 13 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
12 14 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
5 21 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 276.38 | Molecular Weight (Monoisotopic): 276.1626 | AlogP: 4.03 | #Rotatable Bonds: 2 |
Polar Surface Area: 19.03 | Molecular Species: NEUTRAL | HBA: 1 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 2 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 7.23 | CX LogP: 3.98 | CX LogD: 3.76 |
Aromatic Rings: 3 | Heavy Atoms: 21 | QED Weighted: 0.75 | Np Likeness Score: -1.18 |
References
1. Schwarthoff S, Tischer N, Sager H, Schätz B, Rohrbach MM, Raztsou I, Robaa D, Gaube F, Arndt HD, Winckler T.. (2021) Evaluation of γ-carboline-phenothiazine conjugates as simultaneous NMDA receptor blockers and cholinesterase inhibitors., 46 [PMID:34391122] [10.1016/j.bmc.2021.116355] |